Industry News
Pharmaceutical Industry News
Covis granted FDA hearing in latest twist over controversial premature-birth med Makena
Covis granted FDA hearing in latest twist over controversial premature-birth med Makena nhigginsdunn Fri, 08/20/2021 - 11:19
AstraZeneca’s Alexion buy takes first hit as Ultomiris fails in rare neurodegenerative disease
AstraZeneca's Alexion buy takes first hit as Ultomiris fails in rare neurodegenerative disease aliu Fri, 08/20/2021 - 10:56
FibroGen scores a lifeline as Astellas-partnered roxadustat snags EU approval, triggering $120M milestone payment
FibroGen scores a lifeline as Astellas-partnered roxadustat snags EU approval, triggering $120M milestone payment fkansteiner Fri, 08/20/2021 - 09:29
That $56,000 Drug? Blame Medicare.
For an increasingly important set of drugs, Medicare has been driving up prices. It knows how to do better.
Fierce Pharma Asia—China mRNA specialist’s $700M raise; Lilly-Innovent’s Tyvyt win; XtalPi’s AI financing
Fierce Pharma Asia—China mRNA specialist's $700M raise; Lilly-Innovent's Tyvyt win; XtalPi's AI financing aliu Fri, 08/20/2021 - 08:47
Moderna’s ‘Make it Yours’ vaccine campaign taps local partners like Seattle Seahawks, Boston Red Sox
Moderna's ‘Make it Yours’ vaccine campaign taps local partners like Seattle Seahawks, Boston Red Sox bbulik Fri, 08/20/2021 - 08:38
J&J CEO Gorsky to step aside, handing reins of world’s largest pharma to COVID-19 navigator Duato
J&J CEO Gorsky to step aside, handing reins of world's largest pharma to COVID-19 navigator Duato aliu Fri, 08/20/2021 - 06:12
With $35M investment in its flagship New York plant, Curia continues its busy summer of expansion
With $35M investment in its flagship New York plant, Curia continues its busy summer of expansion kdunleavy Thu, 08/19/2021 - 17:17
Alladapt kicks off work at Pennsylvania factory slated to make food allergy hopeful
Alladapt kicks off work at Pennsylvania factory slated to make food allergy hopeful fkansteiner Thu, 08/19/2021 - 16:25
Is NICE becoming nicer? England’s cost-effectiveness watchdog lays out plans to speed access to new medicines
Is NICE becoming nicer? England's cost-effectiveness watchdog lays out plans to speed access to new medicines nhigginsdunn Thu, 08/19/2021 - 15:56
Dexcom and Abbott battle for diabetes device market share in dueling DTC ad campaigns
Dexcom and Abbott battle for diabetes device market share in dueling DTC ad campaigns sharon.coey Thu, 08/19/2021 - 13:24
Giddy up: Alexion challenger Apellis could race to $4B in annual sales with Empaveli, analysts say
Giddy up: Alexion challenger Apellis could race to $4B in annual sales with Empaveli, analysts say nhigginsdunn Thu, 08/19/2021 - 11:26
Biden administration’s push for COVID boosters raises concerns about the science and morality of the plan
Biden administration's push for COVID boosters raises concerns about the science and morality of the plan kdunleavy Thu, 08/19/2021 - 11:22
Glitch in the system: BlackBerry vulnerability could expose medical devices, manufacturing tech to hackers, FDA warns
Glitch in the system: BlackBerry vulnerability could expose medical devices, manufacturing tech to hackers, FDA warns fkansteiner Thu, 08/19/2021 - 09:17
Bristol Myers keeps the perioperative ball rolling with Opdivo nod in postsurgery bladder cancer
Bristol Myers keeps the perioperative ball rolling with Opdivo nod in postsurgery bladder cancer aliu Thu, 08/19/2021 - 08:02
Richard Sackler Says Family and Purdue Bear No Responsibility for Opioid Crisis
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
What to Know About Boosters if You Got the Johnson & Johnson Vaccine
Health experts say that boosters are likely to be needed eventually and that more data should be available in the next several weeks.
Pharma ESG efforts overwhelmingly skew social, while environment and governance come up short: study
Pharma ESG efforts overwhelmingly skew social, while environment and governance come up short: study bbulik Wed, 08/18/2021 - 19:32
Lilly, Boehringer Ingelheim’s Jardiance scores heart failure FDA nod, and an even bigger win could come later this year
Lilly, Boehringer Ingelheim's Jardiance scores heart failure FDA nod, and an even bigger win could come later this year kdunleavy Wed, 08/18/2021 - 16:21
White House rolls out COVID-19 booster plan, but the FDA and CDC have yet to have their say
White House rolls out COVID-19 booster plan, but the FDA and CDC have yet to have their say fkansteiner Wed, 08/18/2021 - 15:48